首页 > 最新文献

International Journal of Radiation Oncology*Biology*Physics最新文献

英文 中文
Neutrophil-to-Lymphocyte Ratio Kinetics and Survival with Neoadjuvant Immuno-chemotherapy and Response-Stratified Chemoradiation in Locoregionally Advanced Head and Neck Cancer 局部晚期头颈癌患者新辅助免疫化疗和反应分层化疗的中性粒细胞与淋巴细胞比率动力学和生存率
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.193
M. Ji, A. Pearson, A. Juloori, E. Vokes, E. Izumchenko, R. Katipally, Z. Gooi, E. Blair, R. Hasina, D. Haraf, N. Agrawal, A. Rosenberg
{"title":"Neutrophil-to-Lymphocyte Ratio Kinetics and Survival with Neoadjuvant Immuno-chemotherapy and Response-Stratified Chemoradiation in Locoregionally Advanced Head and Neck Cancer","authors":"M. Ji, A. Pearson, A. Juloori, E. Vokes, E. Izumchenko, R. Katipally, Z. Gooi, E. Blair, R. Hasina, D. Haraf, N. Agrawal, A. Rosenberg","doi":"10.1016/j.ijrobp.2024.01.193","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.193","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"60 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140357033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing Machine Learning Algorithms Incorporating Patient Reported Outcomes to Predict Disease Progression in Head and Neck Cancers 开发结合患者报告结果的机器学习算法,以预测头颈部癌症的病情进展
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.103
C.M. Yao, K. Hueniken, S.H. Huang, C. Tsai, A. McPartlin, A. Hosni, A. Hope, G. Liu, D. Goldstein, T. Chan, J. de Almeida
{"title":"Developing Machine Learning Algorithms Incorporating Patient Reported Outcomes to Predict Disease Progression in Head and Neck Cancers","authors":"C.M. Yao, K. Hueniken, S.H. Huang, C. Tsai, A. McPartlin, A. Hosni, A. Hope, G. Liu, D. Goldstein, T. Chan, J. de Almeida","doi":"10.1016/j.ijrobp.2024.01.103","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.103","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"16 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140352588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lenvatinib ± Pembrolizumab Versus Chemotherapy for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Progressed after Platinum and Immunotherapy: The Phase 2 LEAP-009 Study 伦伐替尼±Pembrolizumab与化疗联合治疗铂类和免疫疗法后复发/转移性头颈部鳞状细胞癌(HNSCC):LEAP-009 2 期研究
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.095
K. Harrington, H.R. Kim, S. Salas, M. Oliva, R. Metcalf, M. Bernsdorf, J.W. Kim, E. Cohen, L. Siu, D. Rischin, L. Licitra, J. Vermorken, Q. T. Le, M. Tahara, J. Machiels, K. O'Hara, K. Pathiraja, B. Gumuscu, B. Bidadi, B. Burtness
{"title":"Lenvatinib ± Pembrolizumab Versus Chemotherapy for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Progressed after Platinum and Immunotherapy: The Phase 2 LEAP-009 Study","authors":"K. Harrington, H.R. Kim, S. Salas, M. Oliva, R. Metcalf, M. Bernsdorf, J.W. Kim, E. Cohen, L. Siu, D. Rischin, L. Licitra, J. Vermorken, Q. T. Le, M. Tahara, J. Machiels, K. O'Hara, K. Pathiraja, B. Gumuscu, B. Bidadi, B. Burtness","doi":"10.1016/j.ijrobp.2024.01.095","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.095","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"14 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140352609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Impact of Frailty and Geriatric Assessment Identified Impairments among Older adults diagnosed with head and neck cancers 在确诊患有头颈部癌症的老年人中,虚弱和老年评估所确定的损伤的发生率和影响
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.110
K. Siwakoti, S. Giri, L. Nabell, N.A. VanderWalde, A.M. McDonald, G.R. Williams
{"title":"Prevalence and Impact of Frailty and Geriatric Assessment Identified Impairments among Older adults diagnosed with head and neck cancers","authors":"K. Siwakoti, S. Giri, L. Nabell, N.A. VanderWalde, A.M. McDonald, G.R. Williams","doi":"10.1016/j.ijrobp.2024.01.110","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.110","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"12 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140353079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Olaparib, a poly (ADP-ribose) polymerase (PARP) Inhibitor, in Combination with Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC): A Single-Arm, Phase 2 Trial Olaparib是一种多(ADP-核糖)聚合酶(PARP)抑制剂,与Pembrolizumab和卡铂联用作为复发性或转移性头颈部鳞状细胞癌(RM-HNSCC)的一线治疗:单臂 2 期试验
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.096
P. Oppelt, J. Ley, J. Liu, D. Adkins
{"title":"Olaparib, a poly (ADP-ribose) polymerase (PARP) Inhibitor, in Combination with Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC): A Single-Arm, Phase 2 Trial","authors":"P. Oppelt, J. Ley, J. Liu, D. Adkins","doi":"10.1016/j.ijrobp.2024.01.096","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.096","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140354312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brachial Plexus Tolerance To Standard Fractionation Re-irradiation 臂丛神经对标准分次再照射的耐受性
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.128
K. Dibs, E. Gogineni, D. Mitchell, D. Konieczkowski, S. Baliga, S.R. Jhawar, J. Palmer, D. Blakaj
{"title":"Brachial Plexus Tolerance To Standard Fractionation Re-irradiation","authors":"K. Dibs, E. Gogineni, D. Mitchell, D. Konieczkowski, S. Baliga, S.R. Jhawar, J. Palmer, D. Blakaj","doi":"10.1016/j.ijrobp.2024.01.128","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.128","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"63 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140356135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opioid and Adjunctive Medication Prescriptions in Curative-Intent Radiation Therapy for Head and Neck Cancer (HNC) 头颈癌 (HNC) 治疗性瞬时放射治疗中的阿片类药物和辅助药物处方
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.122
S. Khan, R. Lu, B. Lasonde, S. Hawa
{"title":"Opioid and Adjunctive Medication Prescriptions in Curative-Intent Radiation Therapy for Head and Neck Cancer (HNC)","authors":"S. Khan, R. Lu, B. Lasonde, S. Hawa","doi":"10.1016/j.ijrobp.2024.01.122","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.122","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"58 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140356915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twelve Month Follow Up on MARSH: A Pilot, First in Human Study of Autologous IFN-gamma Stimulated Mesenchymal Stromal Cells for Treatment of Radiation-induced Xerostomia MARSH 12 个月随访:自体 IFN-gamma 刺激间充质基质细胞治疗辐射引起的口腔干燥症的首次人体试验研究
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.124
G. Blitzer, T. Glazer, S. Gustafson, A. Burr, R. Pena, R. Mattison, O. Ganz, R. Meyers, M. Weiss, K. McDowell, K. Nickel, R. J. Chappell, N. Pulia, J. Gallipeau, R. J. Kimple
{"title":"Twelve Month Follow Up on MARSH: A Pilot, First in Human Study of Autologous IFN-gamma Stimulated Mesenchymal Stromal Cells for Treatment of Radiation-induced Xerostomia","authors":"G. Blitzer, T. Glazer, S. Gustafson, A. Burr, R. Pena, R. Mattison, O. Ganz, R. Meyers, M. Weiss, K. McDowell, K. Nickel, R. J. Chappell, N. Pulia, J. Gallipeau, R. J. Kimple","doi":"10.1016/j.ijrobp.2024.01.124","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.124","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"55 37","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140357258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Surufatinib for Recurrent or Metastatic Malignant Salivary Gland Tumors: An Open-Label, Single-Arm, Phase II Study 舒伐替尼治疗复发性或转移性恶性唾液腺肿瘤的有效性和安全性:一项开放标签、单臂、II期研究
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.172
W. Jiang, R. Li, G. Zhu
{"title":"Efficacy and Safety of Surufatinib for Recurrent or Metastatic Malignant Salivary Gland Tumors: An Open-Label, Single-Arm, Phase II Study","authors":"W. Jiang, R. Li, G. Zhu","doi":"10.1016/j.ijrobp.2024.01.172","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.172","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"53 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140357354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination of Upfront Systemic Therapy and Radiation in Advanced Non-Melanoma Skin Cancer 晚期非黑色素瘤皮肤癌的前期系统治疗与放疗联合疗法
Pub Date : 2024-04-01 DOI: 10.1016/j.ijrobp.2024.01.170
M. Victor, P. Vaidya, J. Chang, J. Bliamptis, A. Dornisch, P. Sanghvi, T. Guo, S. Park
{"title":"Combination of Upfront Systemic Therapy and Radiation in Advanced Non-Melanoma Skin Cancer","authors":"M. Victor, P. Vaidya, J. Chang, J. Bliamptis, A. Dornisch, P. Sanghvi, T. Guo, S. Park","doi":"10.1016/j.ijrobp.2024.01.170","DOIUrl":"https://doi.org/10.1016/j.ijrobp.2024.01.170","url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"7 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140353879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Radiation Oncology*Biology*Physics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1